Showing results (201-210 of 523) with videos related to
Sort By:
Pageof 53
World Journal of Clinical Oncology|November 3, 2025
Robotic approach for lymphadenectomy of internal mammary lymph nodes in breast cancer: Five case reportsAlessandro Pardolesi, Michele Ferrari, Giovanni Leuzzi, et al.Journal of Thoracic Disease|September 13, 2024
Effectiveness of multi-disciplinary team management on 5-year overall survival for patients with stage III lung cancerCamilla Valsecchi, Andrea Franza, Giorgio Bogani, et al.Pulmonary Pharmacology & Therapeutics|October 11, 2024
Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airwaysMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.Journal of Personalized Medicine|October 27, 2023
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New GloriesMarco Sposito, Lorenzo Belluomini, Letizia Pontolillo, et al.International Journal of Molecular Sciences|November 6, 2019
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of MelanomaErnesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.Critical Reviews in Oncology/Hematology|July 13, 2024
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to successLorenzo Belluomini, Alice Avancini, Marco Sposito, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 15, 2010
Efficacy and safety of TachoSil® versus standard treatment of air leakage after pulmonary lobectomyGabriel Mihai Marta, Francesco Facciolo, Lars Ladegaard, et al.Cancer Treatment Reviews|June 13, 2006
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patientsEmilio Bria, Mariangela Ciccarese, Diana Giannarelli, et al.Expert Opinion on Biological Therapy|November 8, 2008
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issuesEmilio Bria, Federica Cuppone, Michele Milella, et al.Expert Review of Anticancer Therapy|June 13, 2020
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectivesGiulia Sartori, Lorenzo Belluomini, Fiorella Lombardo, et al.Pageof 53